Stockhausen Inc. Overview
Stockhausen is one of the oldest names in Western superabsorbent polymer manufacturing. It is a backward-integrated producer of SAP and its key feedstock, acrylic acid. Its Krefeld site ran the world's first large-scale SAP plant in 1986, and its FAVOR® brand was in more than 40 billion diapers a year by 2011.
After almost two decades inside Degussa and Evonik, the business returned to independence under private-equity-style ownership. ICIG bought it in August 2024 as a standalone "Superabsorber platform" and revived the heritage name. Stockhausen sells only to other businesses. Its customers are global hygiene converters (baby diapers, feminine care, adult incontinence) and niche technical markets: cable water-blocking, swellable elastomers, agricultural water retention and food-packaging pads.
The business has strong application-technology know-how, but it competes in a commoditising, Asia-weighted market. By Evonik's account, it earned thin margins, averaging around €20 million of adjusted EBITDA a year over 2019–2023 on sales of about €0.9 billion. Its investment case rests on a carve-out turnaround, bio-based products and cost discipline.
Company's own description
On its website, Stockhausen calls itself a global manufacturer of superabsorbers that has been "keeping things dry" for more than 40 years. It says its products serve people across the life course: baby diapers, menstrual care and incontinence products, plus agricultural and industrial uses where moisture control matters. Acrylic acid is described as the core of its technology. The company makes acrylic acid for its own SAP and sells some to outside customers. It states that it has belonged to ICIG since 2024 and that it sells B2B only [Source: stockhausen.com About Us and Products, accessed Oct 2026].
ICIG presents Stockhausen as its superabsorber platform, formed in 2024. In ICIG's description, the platform has five manufacturing sites in Europe and the US (an acrylic acid plant in Marl plus SAP plants in Krefeld, Rheinmünster, Greensboro and Garyville) and two R&D and innovation centres in Greensboro and Krefeld. ICIG calls it a full-service supplier to the SAP industry and a leader in application technology [Source: ic-investors.com Stockhausen platform page].
Independent characterisation
Stockhausen is an integrated, mid-tier commodity-to-semi-specialty polymer producer. Its economics depend on three spreads:
Propylene to acrylic acid: at Marl.
Acrylic acid to SAP: across the four SAP plants.
- SAP list prices, which are set through contracts with a concentrated customer base of global diaper makers and private-label converters.
The hygiene grades, mainly FAVOR®, almost certainly make up the large majority of volume and revenue. The technical grades (CABLOC®, CREABLOC®, STOCKOSORB®, FAVOR® Pac) carry higher unit value but are small in tonnage. No product-level split is disclosed.
Business model and revenue model
| Revenue type | Description | Estimated weight | Basis |
|---|---|---|---|
| Product sales: hygiene SAP (FAVOR®) | Tonnage contracts with diaper, feminine-care and incontinence manufacturers | Dominant (exact share not disclosed) | stockhausen.com; Evonik described the unit as "superabsorbents for diapers and hygiene" |
| Product sales: technical SAP | CABLOC® (cable), CREABLOC® (elastomer seals, downhole packers), STOCKOSORB® (horticulture/agriculture), FAVOR® Pac (food pads) | Minor (not disclosed) | stockhausen.com Products |
| Product sales: merchant acrylic acid | Surplus acrylic acid from Marl sold to paints, coatings and flocculant producers | Minor (not disclosed) | stockhausen.com Products |
| Services | Application technology and co-development with customers, bundled into product pricing rather than billed separately | Not separately monetised | stockhausen.com; Evonik 2015 application-centre release |
| Licensing / subscription | None disclosed | — | — |
Value-chain position
The company buys propylene, a petrochemical feedstock, and supplies the Marl acrylic acid plant from it. Marl sits in Chemiepark Marl, a large integrated chemical park. The SAP plants then polymerise and crosslink acrylic acid with caustic soda into SAP granulate. Customers are converters: branded diaper makers and private-label producers. Stockhausen does not sell to consumers.
Customer types and end-markets
| End-market | Products | Customer type |
|---|---|---|
| Baby care (diapers) | FAVOR® | Global and regional diaper OEMs, private-label converters |
| Feminine care | FAVOR® | Hygiene converters |
| Adult incontinence | FAVOR® (including odour-control grades) | Hygiene converters, medical-supply brands |
| Food packaging | FAVOR® Pac (FDA-cleared and EU food-contact compliant) | Absorbent pad makers, meat and poultry packers |
| Wire and cable | CABLOC® | Power and telecom cable makers |
| Civil engineering, oil and gas, geothermal, mining | CREABLOC® | Rubber compounders, makers of swellable seals and packers |
| Horticulture and agriculture | STOCKOSORB® | Nurseries, greenhouses, roof-greening and vertical-farming operators |
| Coatings, paints, flocculants | Acrylic acid | Chemical producers |
Strategy
Stated strategic themes
Stockhausen publishes no annual report or investor-day materials. From its website and owner communications, the main themes are:
-
Heritage and customer intimacy. The Stockhausen name was revived to combine long experience with a clear focus on the future. Co-development and tailored FAVOR® grades are central to the pitch.
-
Backward integration into acrylic acid. Marl is presented as a differentiator for quality and security of supply.
-
Sustainability-led differentiation. Priorities are FAVOR® Bio (cellulose-based, biodegradable SAP), ISCC PLUS mass-balance products with up to 100% allocation, lower CO₂ footprint, less waste, and efficient use of raw materials.
-
Application-technology leadership. ICIG describes Stockhausen as a market leader in application technology with a global team of technical experts.
-
Standalone growth platform. ICIG said at signing that the business, as a new platform, would offer the group new growth opportunities.
Initiatives in the last 24 months (Oct 2024 – Oct 2026)
| Initiative | Date | Description | Targets disclosed? | Source |
|---|---|---|---|---|
| Carve-out and rebrand | Sep–Oct 2024 | Separated from Evonik IT, HR and legal; Stockhausen Superabsorber GmbH registered | No | stockhausen.com News |
| FAVOR® Bio commercialisation | 2025–2026 | Bio-based SAP offered to selected partners; commercial scale signalled as coming | No volume or timing targets | stockhausen.com Products / Sustainability |
| ISCC PLUS mass balance | Ongoing | SAP and acrylic acid in Germany certified | No | stockhausen.com Sustainability |
| Efficiency programmes | Ongoing | Company reports completing significant projects to cut raw-material input factors, waste and by-products | No quantified targets | stockhausen.com Sustainability |
| EcoVadis Silver | 2,025 | Third-party ESG rating; top 15% of assessed companies | — | stockhausen.com |
| Fairness & Inclusion policy | 2025–2026 | Published diversity, fairness and inclusion statement | No metrics | stockhausen.com News |
| Possible North American footprint rationalisation | 2025–2026 (unconfirmed) | Garyville not on the company's site list; WARN aggregator entry | — | stockhausen.com Sites; warnfirehose.com (low reliability) |
| CEO transition | 1 Oct 2026 | New CEO with transformation background | — | stockhausen.com News |
Medium-term financial targets / guidance
None publicly disclosed.
Products & Services
All product descriptions are taken from stockhausen.com (Products page, accessed Oct 2026) unless noted. Pricing is not publicly disclosed for any product. SAP is typically sold under negotiated annual or quarterly contracts, often indexed to raw-material costs; this is an industry norm and is not disclosed by the company.
FAVOR® (hygiene superabsorber)
| Attribute | Detail |
|---|---|
| Description | Crosslinked network of hydrophilic polymer chains that absorbs liquid, turns it into gel and holds it even under pressure |
| Key capabilities | Absorbs up to about 500 times its own weight, depending on the liquid; tailored grades; optional odour control for incontinence and hygiene products |
| Development generations (company account) | 1986: focus on total capacity. Next generation: retention under pressure. 1996: faster absorption, enabling thinner diapers. 1998: better liquid distribution through higher gel permeability |
| Target customers | Makers of baby diapers, feminine-care and adult-incontinence products |
| Launch year | Process developed 1985; large-scale production from 1986 |
| Scale indicator | In more than 40 billion diapers a year (Evonik, 2011) |
| Industry context (company-provided) | Early diapers held about 50 g of cellulose and 2 g of SAP. By 1999, a typical diaper held 18 g of cellulose and 15 g of SAP, and the ratio is now close to 1:1. Total absorption rose from about 100 g to more than 400 g |
| Pricing model | Not publicly disclosed (B2B contract) |
FAVOR® Bio (bio-based / biodegradable superabsorber)
| Attribute | Detail |
|---|---|
| Description | Bio-based SAP approach aimed at hygiene-grade performance. The sustainability page stresses cellulose-based SAP and biodegradability |
| Status | The company describes it as in a focused market phase, discussed directly with selected partners. Commercial-scale supply is signalled as upcoming |
| Target customers | Hygiene brands seeking greener product claims |
| Launch year | Not disclosed (development under Evonik and ICIG; commercial scale pending as of 2026) |
| Pricing | — |
FAVOR® Pac (food-packaging SAP)
| Attribute | Detail |
|---|---|
| Description | SAP for absorbent pads in food packaging (meat, poultry) and leak-protection underlays in transport |
| Key capabilities | Complies with European food-packaging legislation or is FDA-approved, depending on grade; high retention under pressure; fast swelling; resists ageing and microorganisms; supports lightweight pads |
| Regulatory history | Stockhausen, Inc. petitioned the FDA in 1997 (petition 2B4323 amendment) to allow a grafted copolymer of crosslinked sodium polyacrylate with polyvinyl alcohol in poultry pads, made in Greensboro |
| Target customers | Absorbent-pad makers, protein packers |
| Pricing | — |
CABLOC® (wire and cable water-blocking)
| Attribute | Detail |
|---|---|
| Description | Crosslinkable homopolymers with water-binding groups. Insoluble in water when dry but highly swellable; they block water from entering power and telecom cables and seal damaged sections |
| Application methods | Fluidised bed, electrostatic and vibratory application onto tapes, yarns and substrates |
| Key capabilities | Fast swelling, high gel strength, mechanical stability, anti-corrosive, ageing- and microbe-resistant, non-toxic |
| Target customers | Power and communication cable makers; water-blocking tape and yarn producers |
| Pricing | — |
CREABLOC® (swellable elastomer SAP)
| Attribute | Detail |
|---|---|
| Description | Salt-resistant, long-term-stable SAP for elastomer and thermoplastic compounds, usually blended with EPDM to make them swell in water |
| Applications | Swellable rubber seal profiles and gaskets in civil engineering; swellable downhole packers in oil and gas, geothermal and mining |
| Target customers | Rubber compounders, makers of oilfield completion equipment |
| Pricing | — |
STOCKOSORB® (agricultural / horticultural water retention)
| Attribute | Detail |
|---|---|
| Description | SAP mixed into soil or substrate to retain moisture (the company's slogan reverses "keep things dry" to "keep things moist") |
| Application | Mixed by hand, dry or pre-hydrated, into pots, containers and bags; nurseries, greenhouses, roof greening, vertical farming |
| Claimed benefits | Higher seedling survival, better root growth under heat and drought, lower water and fertiliser use, less run-off and erosion, earlier harvest |
| Target customers | Commercial horticulture, landscaping, agriculture, garden centres |
| Pricing | — |
Acrylic acid (merchant sales)
| Attribute | Detail |
|---|---|
| Description | Main raw material for SAP, made at Marl, Germany; surplus sold to third parties |
| Downstream uses | Paints, coatings, flocculants |
| Certifications | ISO 9001, ISO 14001 / EMAS, ISO 50001; ISCC PLUS mass-balance certification in Germany |
| Capacity | — |
| Pricing | Not publicly disclosed (typically indexed to market benchmarks) |
Services
Application technology and co-development: Customers can work with Stockhausen labs on tailored SAP blends. Under Evonik, the business opened a €1 million application-technology centre in Krefeld in April 2015 [Source: Evonik press release, 27 Apr 2015].
Mass-balance certified supply: Products can be supplied with ISCC PLUS mass-balance allocation of up to 100% [Source: stockhausen.com Sustainability].
Financial Narrative
Disclosure context
Stockhausen is privately held and publishes no consolidated accounts. The only verified standalone figures come from Evonik's divestment disclosure in March 2024:
The German GmbH is required to file annual financial statements in the Unternehmensregister. Analysts needing audited figures should pull HRB 20668 filings directly.
Income statement (chartable format; blank = not publicly disclosed)
EPS and DPS do not apply because the company has a single private shareholder.
Margins (chartable format)
Derived observation, not a reported figure. If "mid double-digit millions" is taken as roughly €40–60 million, the FY2023 adjusted EBITDA margin was about 4.5–6.7% of sales. The five-year average of about €20 million against sales of €0.9–1.0 billion implies an average margin near 2%. These are analytical ranges inferred from Evonik's wording, not disclosed numbers, so they are not entered in the chartable table.
Revenue CAGR
This cannot be calculated: only one year (FY2023) is disclosed.
Balance sheet (chartable format)
Context. Evonik impaired €301 million of Performance Materials goodwill in FY2022 [Source: Evonik FY2022 results]. The allocation between superabsorbents and C4 was not disclosed. A purchase price in the low hundreds of millions for about €0.9 billion of sales (roughly 0.1–0.4x EV/Sales) suggests the acquisition balance sheet was valued well below historical book value. That is an inference, not a disclosure.
Ratios
Not publicly disclosed: ROE, ROA, ROIC, current ratio, debt/equity, net debt/EBITDA, interest coverage, asset turnover and cash conversion cycle. None can be calculated without balance-sheet data.
Commentary on trends, inflections and drivers
Evonik's disclosures, though limited, describe a business with structurally low profitability and high cyclicality. EBITDA averaged about €20 million a year over five years on sales of around €0.9 billion. That is thin for an asset-heavy, five-plant, backward-integrated operation, and it probably fell short of covering maintenance capex in some years. This is an inference; capex is not disclosed.
2021–2022. Sales were driven largely by price. Acrylic acid and propylene costs rose sharply in the 2021–2022 commodity spike, and SAP producers passed costs through with a lag. Evonik reported that superabsorbent sales rose in 2022 as market conditions improved.
2023. Sales of €892 million fell year on year because European demand weakened. Even so, the business reached EBITDA in the "mid double-digit millions", above its five-year average. The likely explanation is easing raw-material costs that improved the spread even as volumes and prices fell. This is an inference.
2024 carve-out. The low triple-digit-million price confirms that both Evonik and ICIG saw the asset as a turnaround candidate rather than a stable cash generator.
2025–2026 (no disclosed data). Three qualitative signals stand out:
-
The company's reference to strengthening the business in a challenging market environment (CEO transition release, Oct 2026).
-
The apparent drop from five to four listed sites, with the Garyville facility no longer on the company's site list.
-
A Louisiana WARN Act entry for "Stockhausen Superabsorber" in early 2026 on a third-party aggregator. Its worker count is clearly garbled and unreliable.
Taken together, these signals point to capacity restructuring in North America. This is unconfirmed by the company.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Group Entities
| Entity | Jurisdiction | Role | Source |
|---|---|---|---|
ICI Holding SE / International Chemical Investors Group | Germany (Frankfurt) | Ultimate owner; privately held industrial holding | ic-investors.com |
Stockhausen Superabsorber GmbH | Germany (Krefeld, HRB 20668) | Operating parent; runs Krefeld, Rheinmünster and Marl | stockhausen.com |
Stockhausen Superabsorber LLC | USA | US operating entity, Greensboro (formerly Stockhausen, Inc.) | stockhausen.com Sites; USPTO |
Garyville, LA operation | USA | SAP plant at 3606 LA-44, Garyville; legal entity not confirmed; current status unclear | ic-investors.com Garyville page |
Functional Group Details
| Functional group (analyst construct) | Contents | Products |
|---|---|---|
Hygiene SAP | Baby, feminine and adult-incontinence SAP | FAVOR®, FAVOR® Bio (development/limited commercial) |
Specialty/technical SAP | Industrial and agricultural SAP | FAVOR® Pac, CABLOC®, CREABLOC®, STOCKOSORB® |
Acrylic acid (merchant) | Surplus acrylic acid from Marl | Glacial/crude acrylic acid (grades not disclosed) |
Revenue by Segment
| Metric | FY2023 |
|---|---|
Total business sales (EUR Mn) | 892 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansRevenue by Segment (FY2022–FY2023)
| Metric | FY2022 | FY2023 |
|---|---|---|
Evonik Performance Materials sales (EUR Mn) | 3,660 | — |
Evonik Performance Materials adj. EBITDA (EUR Mn) | 409 | 111 |
Data Point Details
| Data point | Value | Period | Source |
|---|---|---|---|
Sales | €892 million | FY2023 | Evonik press release, 4 Mar 2024 |
Adjusted EBITDA | "Mid double-digit million euro range" (no exact figure) | FY2023 | Evonik press release, 4 Mar 2024 |
Adjusted EBITDA, five-year average | About €20 million per year | Roughly FY2019–FY2023 | Evonik press release, 4 Mar 2024 |
Enterprise value / purchase price | "Low triple-digit million euro range" | Signed Mar 2024; closed 31 Aug 2024 | Evonik press release |
Employees | About 1,000 | 2023/2024 | Evonik closing release |
2023 demand commentary | Sales fell in 2023 on weaker European demand | FY2023 | Specialty Chemicals Magazine |
2022 commentary | Superabsorbent sales rose in 2022, helped by better market conditions | FY2022 | PCI Magazine / Evonik FY2022 |
Income Statement
| Metric | FY2023 |
|---|---|
Revenue (EUR Mn) | 892 |
Region Overview
| Region | Sites | Functions |
|---|---|---|
Germany | Krefeld, Rheinmünster, Marl | SAP (Krefeld, Rheinmünster); acrylic acid (Marl); R&D and application technology (Krefeld) |
United States | Greensboro, NC; Garyville, LA (status uncertain) | SAP; R&D (Greensboro) |
Asia, Latin America, Middle East | No disclosed production | Served by export, if at all |
Capital Markets
| Item | Status |
|---|---|
Share price performance (1/3/5-year) | Not applicable (unlisted) |
Valuation multiples (P/E, EV/EBITDA, EV/Sales, P/B) | Not applicable. Transaction-implied: the low triple-digit million euro price on €892M FY2023 sales implies EV/Sales of roughly 0.1x–0.4x. Against "mid double-digit million" FY2023 EBITDA, EV/EBITDA would be roughly 2x–7x. These are analytical ranges from Evonik's wording, not disclosed multiples |
Analyst consensus | None (no coverage) |
Dividend history and policy | Not publicly disclosed (single private shareholder) |
Credit ratings (Moody's / S&P / Fitch) | None found; no public rating |
Listed peer reference | Nippon Shokubai, BASF, LG Chem, Sumitomo Seika and Formosa Plastics are listed but report SAP inside broader segments; peer SAP multiples cannot be isolated |
Capital Markets Data
| Metric | FY2023 |
|---|---|
Disclosed sales base for valuation (EUR Mn) | 892 |
Analyst Conclusions
Management guidance
None publicly disclosed. Qualitative signals are a focus on transformation (CEO appointment, Oct 2026), FAVOR® Bio commercialisation and efficiency programmes.
Consensus growth expectations
No company consensus exists. For the market, third-party estimates put SAP growth at about 5.8–6.1% a year through the early 2030s [GMI; Reports and Insights], led by Asia-Pacific.
Bull case
-
Turnaround from a low base. A business bought for a low triple-digit million price that reached "mid double-digit million" EBITDA in FY2023 has substantial operating leverage if spreads normalise and carve-out costs are cut.
-
Sustainability premium. FAVOR® Bio and 100%-allocation mass-balance products could earn premium pricing and preferred-supplier status with hygiene brands chasing scope-3 targets.
-
Footprint optimisation. Exiting under-utilised US capacity (if Garyville is confirmed) and focusing on Greensboro and the German sites could raise utilisation and margins.
Bear case
-
Structural cost disadvantage. Three German sites carry European energy and CO₂ costs against Asian rivals with newer capacity.
-
Low historical returns. Average EBITDA of about €20M a year over five years suggests the business may not reliably earn its cost of capital through the cycle.
-
Demographic and customer pressure. Falling birth rates in home markets and strong buyer power among diaper makers cap volume growth and pricing.
Catalysts and monitorables (next 12 months)
-
The new CEO's first strategic announcements (Q4 2026 to H1 2027).
-
Official confirmation of the Garyville site's status and any related restructuring.
-
A FAVOR® Bio commercial-scale launch announcement.
-
Filing of German statutory accounts for FY2024 and FY2025 (Unternehmensregister).
-
European energy prices and acrylic acid spreads.
-
Any ICIG portfolio action (bolt-on acquisitions or a partial sale).
Analyst verdict
The entity searched as "Stockhausen Inc." is not a public company. It is the US arm of Stockhausen Superabsorber, a heritage German SAP and acrylic acid producer that ICIG bought from Evonik in August 2024 for a price Evonik described as in the low triple-digit million euro range. The business has real assets: integrated acrylic acid at Marl, four or five SAP plants, a pioneering technology history going back to the world's first large-scale SAP plant in 1986, a respected brand (FAVOR®) and credible sustainability credentials. Its economics, however, have been poor. Evonik's own numbers show adjusted EBITDA averaging about €20 million a year on sales near €0.9 billion. That profile explains both why Evonik sold and why the price was so low.
Under ICIG, the playbook is clear: separate, simplify, cut costs, rationalise capacity and differentiate through sustainability. There is some public evidence of progress. The carve-out and rebrand are complete, the company holds an EcoVadis Silver rating and ISCC PLUS certification, and FAVOR® Bio is nearing commercial scale. The company's site list now shows four sites rather than five, which suggests the North American footprint is being restructured, though no announcement confirms this. The CEO change on 1 October 2026, bringing in an executive with transformation experience at INEOS Styrolution, signals that the owner wants faster change.
The main limitation of this assessment is disclosure. No post-carve-out financials are public, so any judgement on the turnaround's success is provisional. For counterparties, Stockhausen is likely to remain a technically capable, reliable supplier, especially in Europe and North America. For anyone assessing it as an investment, it is a carve-out turnaround with credible upside if spreads normalise and bio-SAP scales, set against structural pressure from European costs and Asian competition. Treat it as a watch until audited FY2025 accounts and the new CEO's strategy are available.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Title | Tenure | Prior roles | Education |
|---|---|---|---|---|
Dr. Eike Jahnke | CEO / Managing Director, Stockhausen Superabsorber GmbH | From 1 Oct 2026 | Several senior leadership roles at INEOS Styrolution, driving growth and transformation | PhD in chemistry |
Gregor Keil | Former CEO (first post-carve-out leader); now Chief Portfolio Officer, ICIG | Sep 2024 (presumed) – 30 Sep 2026 | — | — |
Jacqueline Skrzeba | Head of Communications | — | — | — |
Michael Krzanowski | Head of Production Support (per third-party professional profile) | 2023–present | Process engineer, INEOS Inovyn (2019–2023) | — |
“—” = not publicly disclosed.
Board Committees
| Body | Member | Role | Source |
|---|---|---|---|
Supervisory Board, Stockhausen Superabsorber GmbH | Christoph Sprenger | Chairman | stockhausen.com Company Information |
ICIG Supervisory Board | Dr. Achim Riemann | Chairman (ICIG group level) | AlChemPro, Sep 2024 |
Board & Management Changes
| Date | Change | Context |
|---|---|---|
1 Sep 2024 | Business moves to ICIG ownership; new management under the Stockhausen name | Carve-out from Evonik |
1 Oct 2026 | Dr. Eike Jahnke appointed CEO; Gregor Keil becomes ICIG Chief Portfolio Officer | Company credits Keil with strengthening the business in a challenging market; Jahnke hired for growth and transformation experience |
Major Shareholders
| Holder | Stake | Source |
|---|---|---|
International Chemical Investors Group (ICI Holding SE) | 100% (presumed; acquired the whole business unit) | Evonik/ICIG releases |
Institutional holders | Not applicable (unlisted) | — |
Competitive Landscape
Key Competitors
| Competitor | HQ | Listing | Relative positioning | Source for inclusion |
|---|---|---|---|---|
Nippon Shokubai | Japan | Listed (Tokyo) | Global leader by capacity; integrated in acrylic acid; plants in Japan, US, Europe and Asia | Market reports (Barchart/MarketsandMarkets; RnR 2014) |
BASF | Germany | Listed (Frankfurt) | Major hygiene SAP supplier with a global footprint | Multiple market reports |
LG Chem | South Korea | Listed (Seoul) | Large Asian SAP producer; strong in eco-friendly SAP | GMI |
Sumitomo Seika Chemicals | Japan | Listed (Tokyo) | Plants in Japan, France and Singapore | RnR 2014 |
SDP Global (Sanyo Chemical / Toyota Tsusho lineage) | Japan | Subsidiary | Long-established SAP supplier | Market reports |
San-Dia Polymers / Sanyo Chemical Industries | Japan | Listed parent | Japanese SAP producer | GMI; market reports |
Formosa Plastics | Taiwan | Listed | Integrated acrylics and SAP | Market reports |
Yixing Danson Technology | China | Unlisted/regional | Named among top-6 capacity holders (2014) | RnR 2014 |
Wanhua Chemical | China | Listed (Shanghai) | Growing Chinese entrant | Future Market Insights (2026) |
Zhejiang Satellite / Weilong / Quanzhou BLD | China | Various | Low-cost Chinese capacity | Market reports |
Kao Corporation | Japan | Listed | SAP for in-house diaper brands | Market reports |
Peer Comparison FY2023
| Metric | Stockhausen | Nippon Shokubai | BASF (SAP) | LG Chem (SAP) |
|---|---|---|---|---|
SAP-related revenue | €892M (FY2023, includes merchant acrylic acid) | Not separately verified here | — | — |
Growth | Declined in FY2023 (Europe) | — | — | — |
Margins | About €20M average adjusted EBITDA (5-year); mid double-digit millions in FY2023 | — | — | — |
Acrylic acid integration | Yes (Marl) | Yes | Yes | Yes |
Asian production | — | Yes | Yes | Yes |
“—” = not publicly disclosed.
Recent Developments
To give useful context, the register starts in March 2024 with the transaction. Entries are marked by source reliability.
Items not found: * product launches with specifications, named contract wins, guidance revisions, litigation, regulatory penalties and quantified hiring.



